>> a lack of diversity among participants. The vast majority of patients were white, with only five Black patients receiving MDMA, raising questions about the generalizability of the results. “The fact that this study has so many white participants is problematic because I don’t want something to roll out that only helps this one group,” said Elizabeth Joniak-Grant, the group’s patient representative.

Imagine letting EVERYONE being off worse because it might not help everyone.

She really should've done reverse racism: do the study on whites since they are the only race for whom it's ok to discriminate in the current zeitgeist.

Instant approval!

Also funny they say "it might not work": I'm pretty sure many people with PTSD are desperate and nothing works for them: those would jump at anything that might help them.

But now they've denied them that. Gotta push pharma pills!